You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

COMT inhibitor

Showing 1 - 25 of 7,423
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Addiction Trial in Berkeley, San Francisco (Tolcapone, Placebo, Bromocriptine)

Withdrawn
  • Addiction
  • Berkeley, California
  • +1 more
Nov 12, 2021

Mild Traumatic Brain Injury Trial in Sacramento (Tolcapone, Placebo)

Completed
  • Mild Traumatic Brain Injury
  • Sacramento, California
    VA Northern California Health Care System, Mather, CA
Feb 23, 2022

Decision Making, Executive Function, Dopamine Trial in Berkeley (Tolcapone 200 MG, Functional Magnetic Resonance Imaging (fMRI))

Recruiting
  • Decision Making
  • +2 more
  • Tolcapone 200 MG
  • Functional Magnetic Resonance Imaging (fMRI)
  • Berkeley, California
    University of California, Berkeley
Jan 13, 2022

Opicapone Treatment Initiation Open-Label Study

Active, not recruiting
  • Parkinson Disease
  • Los Gatos, California
  • +5 more
Apr 7, 2022

Parkinson Disease, Treatment Adherence Trial in Ankara (Levodopa)

Enrolling by invitation
  • Parkinson Disease
  • Treatment Adherence
  • Ankara, Turkey
    Ankara Atatürk Sanatorium Training and Research Hospital
Oct 30, 2023

Parkinson Disease Trial in Anyang-si (Ongentys 50mg, Madopar Tab. 125 or Perkin Tab. 25-100mg)

Recruiting
  • Parkinson Disease
  • Ongentys 50mg
  • Madopar Tab. 125 or Perkin Tab. 25-100mg
  • Anyang-si, Gyeonggi-do, Korea, Republic of
    Hallym University Sacred Heart Hospital
Jun 17, 2021

OCD, OCD Trial (Tolcapone, Placebo)

Not yet recruiting
  • Obsessive-Compulsive Disorder
  • OCD
  • (no location specified)
Nov 14, 2022

Parkinson's Disease Trial in Japan (TVP-1012 1mg, TVP-1012 0.5mg, Placebo)

Completed
Has Results
  • Parkinson's Disease
  • TVP-1012 1mg
  • +2 more
  • Nagoya, Aichi, Japan
  • +56 more
Feb 17, 2022

Parkinson Disease Trial in Paris (Identification of COMT HH, COMT HL or COMT LL genes, Brain MRI with resting state scan, Brain

Completed
  • Parkinson Disease
  • Identification of COMT HH, COMT HL or COMT LL genes
  • +2 more
  • Paris, France
    Groupe Hospitalier Pitié-Salpêtrière
Feb 17, 2022

Healthy Young and Older Adults Trial in Berlin (procedure, drug, other)

Completed
  • Healthy Young and Older Adults
  • tDCS
  • +2 more
  • Berlin, Germany
    Charite Universitätsmedizin Berlin
May 10, 2021

COMT Activity and Hypnotizability

Active, not recruiting
  • Pain, Postoperative
  • Genetic Predisposition
  • Giant magnetoresistive sensor (GMR)
  • Palo Alto, California
    Stanford University/Stanford Healthcare
Aug 23, 2021

Parkinson Trial in Dupnitsa (Opicapone 50 mg, Placebo)

Recruiting
  • Parkinson
  • Opicapone 50 mg
  • Placebo
  • Dupnitsa, Bulgaria
    Medical Centre "Asklepii", OOD
Jul 20, 2021

Peripheral T Cell Lymphoma Trial in Beijing (Linperlisib in combined with Chidamide)

Recruiting
  • Peripheral T Cell Lymphoma
  • Linperlisib in combined with Chidamide
  • Beijing, Beijing/China, China
  • +1 more
Oct 9, 2023

Parkinson's Disease Trial in Japan (TVP-1012 1mg)

Completed
Has Results
  • Parkinson's Disease
  • TVP-1012 1mg
  • Nagoya, Aichi, Japan
  • +23 more
Feb 16, 2022

Cutaneous T-cell Lymphoma Trial in Beijing (Linperlisib in combined with Chidamide)

Recruiting
  • Cutaneous T-cell Lymphoma
  • Linperlisib in combined with Chidamide
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Sep 8, 2023

Cervical Cancer Trial in Amsterdam (Anti-PD-1 antibody balstilimab)

Not yet recruiting
  • Cervical Cancer
  • Anti-PD-1 antibody balstilimab
  • Amsterdam, Netherlands
    Amsterdam UMC
Oct 17, 2023

Pain, Postoperative, Excavatum, Pectus, Scoliosis Idiopathic Trial in Cincinnati (Meditation)

Enrolling by invitation
  • Pain, Postoperative
  • +2 more
  • Meditation
  • Cincinnati, Ohio
    Cincinnati Childrens Hospital Medical Center
Dec 7, 2022

Impulsive Behavior Trial in Berkeley, Emeryville (Tolcapone, Placebo)

Completed
Has Results
  • Impulsive Behavior
  • Berkeley, California
  • +1 more
Nov 18, 2020

Hepatocellular Carcinoma (HCC) Trial in Taiwan (Chidamide, Regorafenib)

Recruiting
  • Hepatocellular Carcinoma (HCC)
  • Kaohsiung, Taiwan
  • +4 more
Mar 14, 2023

Chronic Kidney Disease Trial (Part A - Lorundrostat QD + Dapaglifozin QD, Part A - Lorundrostat QD, Part B - Lorundrostat QD

Not yet recruiting
  • Chronic Kidney Disease
  • Part A - Lorundrostat QD + Dapaglifozin QD
  • +2 more
  • (no location specified)
Nov 27, 2023

HIV Trial in Las Vegas, Austin (VH4004280, Placebo)

Not yet recruiting
  • HIV Infections
  • Las Vegas, Nevada
  • +1 more
Aug 21, 2023

Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer Trial (OP-1250, Fulvestrant, Anastrozole)

Not yet recruiting
  • Breast Cancer
  • +4 more
  • (no location specified)
Aug 31, 2023

Advanced Pancreatic Adenocarcinoma, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Boston (Zentalis, Gemzar)

Not yet recruiting
  • Advanced Pancreatic Adenocarcinoma
  • +2 more
  • Boston, Massachusetts
  • +1 more
Aug 23, 2023

Differentiated Thyroid Cancer Trial in Pavia (Pembrolizumab)

Not yet recruiting
  • Differentiated Thyroid Cancer
  • Pavia, Lombardia, Italy
    Istituti Clinici Scientifici Maugeri
May 5, 2023

Blood Vessel Function in Postmenopausal Women With Breast Cancer

Active, not recruiting
  • Breast Cancer
  • Rochester, Minnesota
    Mayo Clinic
Jan 17, 2023